P&G FY2026: sales $87.03B, organic +1.0%, Q4 core EPS $1.43
P&G closed fiscal 2026 with $87.03 billion of sales, but only 1.0% of that growth was organic, and fourth-quarter core EPS of $1.43 slipped 3.0% and landed just under the $1.4514 consensus. Management's fiscal 2027 plan promises little more than flat-to-modest growth while absorbing $1.00 billion of after-tax cost headwinds. That mix of steady cash returns and stalled underlying volume reads as Neutral; here is where the money actually went.
1 · Expected vs. Actual
Free preview belowFull-year diluted EPS was $6.62, up 2.0%, and core EPS was $6.89, up 1.0%; currency-neutral core EPS was unchanged versus the prior year. The fourth quarter is the worry: diluted EPS of $1.26 fell 15.0% and core EPS of $1.43 fell 3.0%. Core EPS of $1.43 also came in just below the $1.4514 consensus estimate.
Fiscal 2026 net sales were $87.03 billion, up 3.0% from $84.28 billion, but the entire gain came from currency (2.0%) and pricing (1.0%) - volume and mix were unchanged. Organic sales, which strips out foreign exchange and deal effects, rose just 1.0%. The fourth quarter was weaker still: sales of $21.20 billion rose 2.0%, but organic sales were flat at 0.0%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.